Logo-jnp
J Nephropathol. 2022;11(2): e17276. doi: 10.34172/jnp.2022.17276

Review

Role of oxidant-antioxidant enzymes in managing the cardiovascular risks in nephrotic syndrome patients

Souparnika Sreelatha 1 * ORCID, Benedicta D'souza 2, Vivian D'souza 3, Kalaiselvi Rajendiran 4

Cited by CrossRef: 0

1- Kanai T, Ogiso H, Aoyagi J, Kurosaki M, Maru T, Ishii M, Tanimoto K, Yoshino M, Yamashita Y, Tajima T, Nagai R, Aizawa K. Altered Sphingolipids, Glycerophospholipids, and Lysophospholipids Reflect Disease Status in Idiopathic Steroid-Sensitive Nephrotic Syndrome in Children: A Non-Targeted Metabolomic Study. Cells. 2025;14(24):1950 [Crossref]
2- Ismail A, Al-kuraishy H, Al-Gareeb A, Alexiou A, Papadakis M, Faheem S, Batiha G. Unveiling the Neuroprotective Effect of Paraoxonase 1 in Neurodegenerative Diseases Focusing on Alzheimer’s Disease. Mol Neurobiol. 2026;63(1) [Crossref]